They continue to decline for all four major cancers: lung, colorectal, breast and prostate. But the largest improvements in survival have been for leukemia and non-Hodgkin's lymphoma.
Still, not all have benefited equally. Minority men have a greater chance of dying from cancer within five years of diagnosis.
African-Americans remain less likely than whites to get standard cancer therapies.
The American Cancer Society says these numbers could improve further by better educating all segments of the population.
